Co-discoverers of the link between the gene EIF2AK4 and specific types of pulmonary hypertension, Intermountain and ARUP are now collaborating to offer clinical testing.
A commentary in NEJM argues that precision medicine will require clinicians and patients to be more comfortable with risk and probability.
In its SEC filing, the company said it has already sold $562,500 of units which consist of Series B-2 preferred shares and warrants to purchase more.
Results from the Rheumatoid Arthritis Responder Dream Challenge did not support the use of common SNP data to improve treatment response prediction models.
The company recently released an RUO RNA extraction kit, and plans to launch a liquid biopsy pan-cancer test and disease-specific NGS panels later this year.
In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.
Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.
MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.
Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.